Aligos Therapeutics, Inc. - COM (ALGS)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
46.2 M
Holdings value Q1 2024
$45.3 M
Value change Q1 2024
+$1.76 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
47
Number of buys Q1 2024
23
Number of sells Q1 2024
-7
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
01626L105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 46.2 M $45.3 M +$1.76 M $0.98 48
2023 Q4 45.3 M $30.1 M +$11 M $0.66 37
2023 Q3 23.4 M $17.5 M -$456 K $0.75 34
2023 Q2 26.3 M $25.5 M -$906 K $0.97 41
2023 Q1 27.3 M $23.9 M +$713 K $0.87 43
2022 Q4 26.5 M $25.3 M -$1.39 M $0.95 37
2022 Q3 27.5 M $30.3 M -$2.48 M $1.10 42
2022 Q2 29.2 M $35.3 M -$4.69 M $1.21 51
2022 Q1 30 M $64.6 M -$40.1 M $2.15 67
2021 Q4 32.9 M $390 M +$18.5 M $11.87 66
2021 Q3 31.2 M $484 M +$61.7 M $15.51 68
2021 Q2 27 M $550 M -$8.07 M $20.39 55
2021 Q1 26.4 M $598 M -$9.75 M $22.74 49
2020 Q4 27.3 M $749 M +$725 M $27.65 50